Article Details

Prescient Therapeutics appoints leading brain cancer specialist to advisory board - Small Caps

Retrieved on: 2021-08-19 00:00:00

Tags for this article:

Click the tags to see associated articles and topics

Prescient Therapeutics appoints leading brain cancer specialist to advisory board - Small Caps. View article details on hiswai:

Excerpt

Clinical stage oncology company Prescient Therapeutics (ASX: PTX) has ... Prescient managing director Steven Yatomi-Clarke said Professor ...

Article found on: smallcaps.com.au

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up